Published in J Pediatr on May 01, 1972
Immunologic and genetic factors influencing reproduction. A review. Am J Pathol (1979) 1.12
Leukocyte antigen and antibody detection assays: tools for assessing and preventing pulmonary transfusion reactions. Transfus Med Rev (2007) 1.07
Effects of anti-human neutrophil antibodies in vitro. Quantitative studies. J Clin Invest (1974) 1.02
Use of granulocyte colony-stimulating factor during pregnancy in women with chronic neutropenia. Obstet Gynecol (2015) 0.77
Auto-immune neutropenia in an infant. Postgrad Med J (1978) 0.75
A rapid, simple, sensitive method for measuring fibrinolytic split products in human serum. Proc Soc Exp Biol Med (1969) 4.70
The mouse homolog of Drosophila Vasa is required for the development of male germ cells. Genes Dev (2000) 3.93
Left-right asymmetric expression of the TGF beta-family member lefty in mouse embryos. Nature (1996) 3.79
Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood (2000) 3.45
CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge. J Virol (1996) 3.39
The biochemical basis of nitroblue tetrazolium reduction in normal human and chronic granulomatous disease polymorphonuclear leukocytes. Blood (1976) 2.76
NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins (1994) 2.60
Mouse Pitx2 deficiency leads to anomalies of the ventral body wall, heart, extra- and periocular mesoderm and right pulmonary isomerism. Development (1999) 2.57
Parthenogenetic activation of oocytes in c-mos-deficient mice. Nature (1994) 2.40
Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. J Clin Invest (1998) 2.36
Neutrophil action dysfunction and abnormal neutrophil behavior. N Engl J Med (1974) 2.35
A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood (1993) 2.29
Erythroid transcription factor GATA-1 is abundantly transcribed in mouse testis. Nature (1993) 2.25
Autooxidation as a basis for altered function by polymorphonuclear leukocytes. Blood (1977) 2.10
Peg3 imprinted gene on proximal chromosome 7 encodes for a zinc finger protein. Nat Genet (1996) 2.06
Regulation of interleukin 8 gene expression by oxidant stress. J Biol Chem (1993) 2.02
Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces. Infect Immun (1991) 1.99
Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. J Control Release (2000) 1.96
Risk factors for hemorrhage from gastric fundal varices. Hepatology (1997) 1.92
Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res (1995) 1.89
Coronary arteriovenous fistula. Nine operated cases. Am Heart J (1966) 1.89
NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel. Br J Cancer (2005) 1.87
Supersensitivity of atherosclerotic rabbit aorta to ergonovine. Mediation by a serotonergic mechanism. J Clin Invest (1980) 1.84
A mew method for detection of red blood cell antibodies. Transfusion (1970) 1.81
Peg1/Mest imprinted gene on chromosome 6 identified by cDNA subtraction hybridization. Nat Genet (1995) 1.67
Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation. Br J Cancer (1997) 1.65
Development of the polymer micelle carrier system for doxorubicin. J Control Release (2001) 1.64
Microbicidal/cytotoxic proteins of neutrophils are deficient in two disorders: Chediak-Higashi syndrome and "specific" granule deficiency. J Clin Invest (1988) 1.63
Lactoferrin: a promoter of polymorphonuclear leukocyte adhesiveness. Blood (1981) 1.57
Regulation of tight junction permeability and occludin phosphorylation by Rhoa-p160ROCK-dependent and -independent mechanisms. J Biol Chem (2001) 1.57
Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. Blood (2000) 1.54
Bone metastasis and poor performance status are prognostic factors for survival of carcinoma of unknown primary site in patients treated with systematic chemotherapy. Ann Oncol (2009) 1.54
Conversion of normal behavior to shiverer by myelin basic protein antisense cDNA in transgenic mice. Science (1988) 1.53
Alteration in energetics in patients with left ventricular dysfunction after myocardial infarction: increased oxygen cost of contractility. Circulation (1996) 1.53
Correction of leukocyte function in Chediak-Higashi syndrome by ascorbate. N Engl J Med (1976) 1.52
Human small Maf proteins form heterodimers with CNC family transcription factors and recognize the NF-E2 motif. Oncogene (1997) 1.50
Two independent pathways of maternal cell transmission to offspring: through placenta during pregnancy and by breast-feeding after birth. Immunology (2000) 1.49
Effect of L-arginine administration on myocardial thallium-201 perfusion during exercise in patients with angina pectoris and normal coronary angiograms. J Nucl Cardiol (2000) 1.49
Interleukin-10 gene transfer improves the survival rate of mice inoculated with Escherichia coli. Crit Care Med (2000) 1.46
Reversal of neutropenia with intravenous gammaglobulin in autoimmune neutropenia of infancy. Blood (1983) 1.42
Chronic urticaria associated with aseptic meningitis: an atypical urticarial vasculitis? Acta Paediatr Jpn (1997) 1.40
Improvement of SSPE by intrathecal infusion of alpha-IFN. Neurology (2004) 1.40
Mouse ATF-2 null mutants display features of a severe type of meconium aspiration syndrome. J Biol Chem (1999) 1.39
Polarization mode control of two-dimensional photonic crystal laser by unit cell structure design. Science (2001) 1.39
Bronchial hyperreactivity in patients with mitral valve disease. Chest (1990) 1.39
Requirement of activation of the extracellular signal-regulated kinase cascade in myocardial cell hypertrophy. J Mol Cell Cardiol (2000) 1.38
Familial adult onset primary alveolar hypoventilation syndrome. Intern Med (2001) 1.38
Reduced hypoxic pulmonary vascular remodeling by nitric oxide from the endothelium. Hypertension (2001) 1.35
DNA immunization with minigenes: low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitination. J Virol (1998) 1.34
Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet (1986) 1.34
Induction and expression of amphiregulin in human pancreatic cancer. Cancer Res (1994) 1.32
Interactions of actin, myosin, and an actin-binding protein of chronic myelogenous leukemia leukocytes. J Clin Invest (1976) 1.31
Spleen colony-forming cell as common precursor for tissue mast cells and granulocytes. Nature (1981) 1.31
Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate). J Control Release (1999) 1.30
Effects of a chemotactic factor, N-formylmethionyl peptide, on adherence, superoxide anion generation, phagocytosis, and microtubule assembly of human polymorphonuclear leukocytes. J Lab Clin Med (1979) 1.30
Auto-oxidative damage in Behçet's disease--endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clin Exp Immunol (1982) 1.29
Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits. Atherosclerosis (2001) 1.28
Increased risk of hepatoblastoma among immature children with a lower birth weight. Cancer Res (1998) 1.28
The formation of ceramide-1-phosphate during neutrophil phagocytosis and its role in liposome fusion. J Biol Chem (1998) 1.27
Resistance to endotoxin shock in transgenic mice overexpressing endothelial nitric oxide synthase. Circulation (2000) 1.27
Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker muscular dystrophy. J Clin Invest (1997) 1.27
Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice. Proc Natl Acad Sci U S A (1998) 1.26
Actin cytoskeletal function is spared, but apoptosis is increased, in WAS patient hematopoietic cells. Blood (2000) 1.26
Induction of platelet-derived growth factor A and B chains and over-expression of their receptors in human pancreatic cancer. Int J Cancer (1995) 1.26
Progression of T cell lineage restriction in the earliest subpopulation of murine adult thymus visualized by the expression of lck proximal promoter activity. Int Immunol (2001) 1.26
Endothelial NO synthase overexpression inhibits lesion formation in mouse model of vascular remodeling. Arterioscler Thromb Vasc Biol (2001) 1.24
Inhibition of polymorphonuclear leukocyte adherence by prostacyclin. J Lab Clin Med (1980) 1.24
Paraplegia caused by painless acute aortic dissection. Spinal Cord (2000) 1.24
Physical entrapment of adriamycin in AB block copolymer micelles. Pharm Res (1995) 1.24
Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer. Cancer Res (1994) 1.23
In vitro inhibition of granulopoiesis by 4-amino-4'-hydroxylaminodiphenyl sulfone. Br J Haematol (1980) 1.21
Metabolic, membrane, and functional responses of human polymorphonuclear leukocytes to platelet-activating factor. Blood (1982) 1.20
Thrombospondin stimulates motility of human neutrophils. J Cell Biol (1990) 1.20
Expression of NADH/NADPH oxidase p22phox in human coronary arteries. Circulation (1999) 1.20
Disruption of the epilepsy KCNQ2 gene results in neural hyperexcitability. J Neurochem (2000) 1.20
Fructose-2,6-P2, chemistry and biological function. Mol Cell Biochem (1982) 1.20
New effectors of human hemoglobin: structure and function. Biochemistry (1990) 1.19
Depolarizing stimuli regulate nerve growth factor gene expression in cultured hippocampal neurons. Proc Natl Acad Sci U S A (1991) 1.19
Phagocytosis of neutrophils by marrow macrophages in childhood chronic benign neutropenia. J Pediatr (1981) 1.19
Regulation of fructose-6-phosphate 2-kinase by phosphorylation and dephosphorylation: possible mechanism for coordinated control of glycolysis and glycogenolysis. Proc Natl Acad Sci U S A (1982) 1.19
Lactoferrin deficiency associated with altered granulocyte function. N Engl J Med (1982) 1.17
Effect of alpha-2 glycoprotein on the immune response. Transplantation (1965) 1.17
Altered cholesterol metabolism in human apolipoprotein E4 knock-in mice. Hum Mol Genet (2000) 1.17
Cyclic AMP-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells. Synergism with the induction elicited by inflammatory cytokines. J Biol Chem (1993) 1.16
The manual polybrene test: a simple and rapid procedure for detection of red cell antibodies. Transfusion (1980) 1.16
Biodistribution of micelle-forming polymer-drug conjugates. Pharm Res (1993) 1.16
Functions of human monocyte and lymphocyte subsets obtained by countercurrent centrifugal elutriation: differing functional capacities of human monocyte subsets. J Immunol (1981) 1.16
Angiotensin II induces circadian gene expression of clock genes in cultured vascular smooth muscle cells. Circulation (2001) 1.16
Tertiapin potently and selectively blocks muscarinic K(+) channels in rabbit cardiac myocytes. J Pharmacol Exp Ther (2000) 1.16
Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Med Sci (2001) 1.15
Expression of glutaredoxin in human coronary arteries: its potential role in antioxidant protection against atherosclerosis. Arterioscler Thromb Vasc Biol (2001) 1.15
Monocyte aggregation and superoxide anion release in response to formyl-methionyl-leucyl-phenylalanine (FMLP) and platelet-activating factor (PAF). J Immunol (1982) 1.15
Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation (1998) 1.15
Association between gelatinase release and increased plasma membrane expression of the Mo1 glycoprotein. Blood (1987) 1.14
Volume of the spleen in children as measured on CT scans: normal standards as a function of body weight. AJR Am J Roentgenol (1993) 1.13
Cellular expression, developmental regulation, and phylogenic conservation of PEA-15, the astrocytic major phosphoprotein and protein kinase C substrate. J Neurochem (1995) 1.13
Purified human plasma kallikrein aggregates human blood neutrophils. J Clin Invest (1982) 1.13
Neutrophil-specific antigens: immunology and clinical significance. Semin Hematol (1974) 1.13
Expression of hsp90 and cyclin D1 in human breast cancer. Cancer Lett (1999) 1.13
Diminished polymorphonuclear leukocyte adherence. Function dependent on release of cyclic AMP by endothelial cells after stimulation of beta-receptors by epinephrine. J Clin Invest (1980) 1.13